{"prompt": "['Boehringer Ingelheim', '16 Dec 2019', 'BI Trial No.: 1199-0324', 'c19558808-06', 'Clinical Trial Protocol', 'Page 58 of 103', 'Proprietary confidential information \u00a9 2019 Boehringer Ingelheim International GmbH or one or more of its affiliated companies', 'Time of exercise: No visual cues regarding the time of exercise should be provided to the', \"subject. The subject's watch should be removed prior to exercise, and all other timekeeping\", 'devices (e.g., trial staff watches, wall clocks, stopwatch etc.) should be kept away from the', \"subject's view.\", 'Familiarity with surroundings: Trial staff should allow as much time as necessary for the', 'subject to become comfortable with the laboratory surroundings.', 'Distractions: During the exercise tests, access to the laboratory should be restricted to trial', 'staff as much as possible. The noise level in the laboratory should be kept to a minimum,', 'except for those sounds specifically related to the conduct of the test. This will ensure that the', 'subject is able to concentrate on the task at hand, and will also ensure that the subject is', 'attentive to the verbal encouragement provided by the designated member of the trial team.', 'Comfort with equipment: Subjects should be appropriately dressed for exercise (e.g., shorts', 'or track pants, gym shoes, T-shirt or sweat shirt), and trial staff should ensure that the subject', 'is comfortable with the equipment prior to starting the exercise.', 'Familiarity with test: Before starting exercise, a member of the trial team should make sure', 'that the subject is completely familiar with the type of exercise that is to be performed, a', 'practice test is expected prior to the baseline test at Visit 2 to allow patients to become', 'familiar with the testing procedures.', 'Performance incentives: No external incentives for performance (i.e., rewards for', 'performance) should be given to the subject, prior to or at any time during the exercise.', 'Personnel qualifications:', 'Exercise challenges should be conducted by adequately trained personnel with a basic', 'knowledge of exercise physiology.', 'Technicians familiar with normal and abnormal responses during exercise and trained in CPR', 'should be present throughout the tests.', 'Safety issues:', 'Cardiac (bradyarrhythmias, ventricular tachycardia, myocardial infarction, heart failure,', 'hypotension, and shock) and non-cardiac (musculoskeletal trauma, severe fatigue, dizziness,', 'fainting, body aches) complications of exercise challenges have been reported.', 'Consequently during the test, study personnel should be alert to any abnormal event.', 'Indications to stop the test must be clearly established and known by the personnel involved', 'in testing.', '001-MCS-40-106-RD-03 (14.0) / Saved on: 17 October 2016']['Boehringer Ingelheim', '16 Dec 2019', 'BI Trial No.: 1199-0324', 'c19558808-06', 'Clinical Trial Protocol', 'Page 59 of 103', 'Proprietary confidential information \u00a9 2019 Boehringer Ingelheim International GmbH or one or more of its affiliated companies', 'Symptoms such as:', '- acute chest pain,', '- sudden pallor,', '- loss of co-ordination,', '- mental confusion,', '- extreme dyspnoea.', 'If the exercise test has been stopped for one of these reasons, the subject should be monitored', 'in the laboratory until signs / symptoms / ECG modifications have completely cleared. Full', 'CPR equipment should be available in the laboratory. Further participation in any exercise', 'testing and continuation of the patient in the study should be discussed with the clinical', 'monitor.', '10.1.2', 'Six-minute walk test', 'A full description of the six minute walk test will be provided in both the instructions and', 'instructional video.', 'Testing should be performed in a location where a rapid, appropriate response in the event of', 'an emergency is possible and emergency instructions in the manual should be followed.', 'During the 6-MWT patients will be monitored for both HR and SpO2 using pulse oximeter.', 'If SpO2 decreases to below 80% at any time after the patients begins walking, first ensure the', 'oximeter is connected and working properly and ensure that a confident pulse signal is', 'generated. If SpO2 is still below 80%, stop the study and allow the subject to sit and rest, the', 'study is complete.', 'The distance walked will be measured in feet (f) and will be recorded. If the test is stopped', 'prematurely, the distance (f), the duration (min), and the reason for stopping will be recorded.', 'Patients will be asked to rate the intensity of dyspnea (shortness of breath) and fatigue using', 'the Modified Borg Scale (see Section 10.2) as described in the instructions.', 'Assessments will be recorded in a worksheet during the testing, and transferred to the eDC', 'system.', '001-MCS-40-106-RD-03 (14.0) / Saved on: 17 October 2016']\n\n###\n\n", "completion": "END"}